3B BlackBio Dx Ltd Board Meeting on Aug 13 to Approve Q1 Results

3B BlackBio Dx Ltd has announced that its Board of Directors will convene on August 13, 2026, to consider and approve the Unaudited Standalone and Consolidated Financial Results for the first quarter ended June 30, 2026. The meeting is scheduled for 3:00 P.M. at the company's registered office. Concurrently, the company has informed that the trading window for its equity shares will remain closed for designated persons and their immediate relatives from July 1, 2026, until 48 hours after the announcement of the financial results on August 13, 2026.